Recombinant Rat CB2 is typically expressed in prokaryotic systems (e.g., E. coli) with modifications for solubility and purification:
Expression tags: N-terminal His-tag for affinity chromatography .
Stability: Lyophilized powder stored at -20°C/-80°C to prevent degradation .
Immune modulation: Regulates cytokine secretion in hematopoietic cells and macrophages .
Pain signaling: Interacts with endocannabinoids like 2-AG to modulate nociception .
Neuroprotection: Expressed in dopamine neurons, where it influences psychomotor behavior and alcohol reward pathways .
Binding assays: Studying interactions with agonists (e.g., JWH-015) or antagonists (e.g., SR144528) .
Signaling pathway analysis: Investigating G protein coupling (Gi/Go) and cAMP regulation .
Cancer research: Evaluating CB2’s role in suppressing EGF/EGFR or IGF-I/IGF-IR signaling in breast cancer .
| Aspect | Rat CB2 | Mouse CB2 |
|---|---|---|
| mRNA isoforms | CB2A, CB2B, CB2C, CB2D | CB2A, CB2B |
| Brain expression | Lower in DA neurons | Higher in DA neurons |
| Behavioral impact | Reduced locomotion | Enhanced psychomotor activity |
CNS effects: Rat CB2’s lower expression in dopamine neurons may contribute to species differences in alcohol reward and anxiety-like behaviors .
Inflammatory responses: Rat CB2’s distinct mRNA isoforms (CB2C/D) may alter regional expression patterns during neuroinflammation .
Post-translational modifications: Absence of glycosylation in E. coli-expressed CB2 may affect receptor conformation .
Species extrapolation: Rat-specific isoforms (CB2C/D) complicate direct translation of findings to human or murine models .
Antibody specificity: Polyclonal antibodies (e.g., Bioss bs-2377R) may cross-react with melanocortin receptors in certain tissues .